Find an expert

Julie Cichero, PhD is a clinician (SLP), is recognised nationally and internationally as a researcher and research professional with more than 30 years clinical and research experience into eating, drinking and swallowing problems (dysphagia). As Co-Founder of IDDSI (Global) Julie co-led development and international roll out of the IDDSI Framework, an initiative to reduce food-related choking risk in vulnerable populations. The IDDSI Framework has been translated into more than 30 languages and is used in more than 50 countries around the world. Julie is the Director of Eat Drink Swallow Safe https://eatdrinkswallowsafe.com.au/. Julie is a consultant to professional societies, government organisations, academia, boards and healthcare organisations. She has made significant contributions to the evidence base for standardised terminology for texture modified food and thick liquids, diagnostic use of swallow-respiratory sounds, characterisation of thick fluids and the complexities associated with medication management in dysphagia.

Bronwyn Clark is an epidemiologist specialising in the field of measurement of physical activity and sedentary behaviour. She is currently working as a Senior Research Fellow at the School of Human Movement and Nutrition Sciences, The University of Queensland funded by UQ Amplify following completion of her National Health and Medical Research Council of Australia Fellowship. Dr Clark is an internationally recognised expert in the measurement of physical behaviour using both self-report and objective methods including newer combined methods such triggered ecological momentary assessment and the use of mmWave technology. She has a particular interest in workplace health behaviour but also works with clinical and broader adult populations. Dr Clark was President of International Society for the Measurement of Physical Behaviour from 2020-2022 and continues on the Board as past-president of the society.

An ecologist by training – I hold a B.Sc. (Hons) in Marine Ecology from the University of North Carolina, Wilmington and a Ph.D. in Ecological Modelling from Griffith University. I am broadly interested in exploring new ways to (1) understand how natural communities are formed and (2) predict how they will change over time. As an Amplify Fellow at UQ, my current research focuses on developing computational tools and adapting techniques from epidemiology and statistical forecasting to study how organisms and ecosystems respond to environmental change. This work is being applied to investigate natural dynamics for a range of natural systems including host-parasite interactions, wildlife populations and veterinary diseases.

I am an active member of the R community and have written and/or maintain several popular R packages. For example, I’m a lead developer on the MRFcov package for multivariate conditional random fields analyses. I also wrote the mvgam R package for fitting dynamic Generalised Additive Models to analyse and forecast multivariate ecological time series, and I regularly provide training seminars and workshops to help researchers learn techniques in ecological data analysis.

I am currently seeking Honours and PhD candidates with interests and/or skills in veterinary epidemiology, spatial / spatiotemporal modeling and quantitative ecology.

Dr Clark is an Associate Professor at the School of Biomedical Sciences where he is Head of the Peptide Chemical Biology Lab. He completed his PhD in 2000 at the UQ Chemistry Department studying marine natural products chemistry and chemical ecology with Prof. Mary Garson. He then shifted his research focus towards peptide chemistry, structural biology and drug design when he was recruited to the lab of Prof. David Craik at the IMB. His current research focus is the development of technologies to stabilise peptide therapeutics and the elucidation of the structure/function activity of bioactive peptides.

Professor David A Clark

Royal Brisbane and Women’s Hospital, and University of Queensland, Australia

Prof Clark is a visiting colorectal surgeon at the Royal Brisbane and Women’s Hospital. He qualified from the University of QLD in 1991, trained in surgery in Brisbane, and undertook colorectal fellowships in the United Kingdom. He was admitted as a Fellow of the Royal College of Surgeons at Edinburgh in January 2002.

He is a Professor for the University of QLD and runs a busy clinical practice at the St Vincent's Private Hospital Northside. He has a strong interest in inflammatory bowel disease and the IBD Unit at the RBWH has an active academic program. Prof Clark has presented internationally in the field of IBD and minimally invasive colorectal surgery.

The colorectal unit based at the RBWH has a commitment to education and runs a regular laparoscopic colorectal training course and now supports 3 colorectal fellows and a research co-ordinator. He is a board member of the ANZ Training Board in Colorectal Surgery (ANZTBCRS) and the recent convenor for the Society and Section scientific meetings.

Prof Clark heads the Brisbane Colorectal Reseacrh Unit (CRU) and completed a PhD at the University of Sydney in June 2022. He concurrently supervised 4 PhD candidates through UQ. He is widely published in the fields of minimally invasive surgery and inflammaory bowel disease.

Brisbane is renowned for minimally invasive colorectal surgery and training and teaching are a passion.

Prof Bill Clarke (Schools of Civil and Chemical Engineering) has an extensive publication record in methods for accelerating the solubilisation and digestion of solid organic waste, measuring landfill emissions and the ingress of O2 and subsequent composting of waste in landfills, the utilisation of waste as a carbon source for H2S production in the mineral processing industry, on-site digestion of combined wastewater and solid organic waste and the fate of pathogens, heavy metals and POPs in organic treatment processes. He was an Associate Editor of Waste Management (2008-13) and is on the Managing Board of the International Waste Working Group.

Paul Clarke is Director of the Frazer Institute, a leading translational medical research centre studying cancer, autoimmune diseases, infection and immunity, and the genetic basis of disease. Professor Clarke became Director in 2017 and was previously Associate Dean (Research) in Medicine at the University of Dundee in Scotland, Senior Research Fellow at the University of Manchester in England, and Research Fellow at the European Molecular Biology Laboratory in Heidelberg, Germany. Professor Clarke studied Biochemistry at the University of Bristol and undertook research for his PhD at the University of Dundee.

Frazer Institute, formerly UQ Diamantina Institute, is named in honour of its Founding Director, Emeritus Professor Ian Frazer, co-discoverer of the Gardasil HPV cervical cancer vaccine. Frazer Institute is part of The University of Queensland Faculty of Medicine and is a key partner in the Translational Research Institute, a $360 million research facility at the Princess Alexandra Hospital precinct in Woolloongabba. Scientists and clinical researchers at Frazer Institute develop new methods for the prevention, detection and treatment of human diseases.

Peter Clarkson undertakes research and teaching in both accounting and finance. His current research interests encompass issues relating to voluntary disclosure (both of a financial and a non-financial nature), company performance and valuation, and the economic implications of environmental performance. His work has been published in academic journals including The Accounting Review (TAR), Journal of Accounting and Economics (JAE), Contemporary Accounting Research (CAR), Accounting, Organisations and Society (AOS), Journal of Accounting and Public Policy (JAAP), Abacus, Journal of Finance (JF), and Journal of Financial and Quantitative Analysis (JFQA)., as well as in professional periodicals. He is currently an Editor of Contemporary Accounting Research and Associate Editor for Journal of Business Finance & Accounting, Journal of International Accounting Research, and Journal of Contemporary Accounting and Economics.

From 2020 Andrew has led research development at the Tess Cramond Pain and Research Centre (Royal Brisbane and Women's Hospital). Topics including clinical outcome measures, service evaluation and strategic planning, clinical trials employing pain education, opioid management, quantitative sensory testing and medical procedures. Current and recent projects include:

• Initiating the Pelvic Exenteration Pain Management Research Collaboration in 2024: A multidisciplinary community of clinicians and researchers at the Tess Cramond Pain and Research Centre, the Royal Prince Alfred Hospital, the Royal Brisbane and Women's Hospital, and the STARS Hospital, to study how the quality of life can be improved for people who have pelvic organs and tissues removed to manage cancer.
• Collaboration with the Institute of Urban Indigenous Health, to embed multidisciplinary research and quality improvement in the co-design and implementation of collaborative care between the TCPRC- IUIH, at the Moreton Aboriginal and Torres Strait Islander Community Health Service in Caboolture through 2023-2024.
• Contributing to the non-surgical pain management stream for the NHMRC-NIHR Collaborative Research Grant, for a multicentre RCT on the clinical and cost-effectiveness of lumbar fusion surgery for patients with persistent, severe low back pain: Short: FusiOn veRsus bEst coNServatIve Care (the FORENSIC trial)
• The LIDOPAIN RCT in 2023: Lidocaine Infusion Dose Optimisation for Pain After Injury to Nerves, was a double-blind placebo-controlled pilot feasibility study for lidocaine infusions, with comprehensive pre-post evaluation of patient questionnaires and sensory testing profiles, to identify which patients do and to not respond to this infusion. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382966&isReview=true
• Advisor for Phoebe Ng, oral thesis defense 2024: Adolescent idiopathic scoliosis: Insights into health profile and paraspinal muscle activation.
• Advisor for Fraser Labrom, thesis awarded 2023: Three dimensional analysis of adolescent idiopathic scoliosis during growth.
• Collaboration with UQ RECOVER Injury Research Centre have
  • Currently completing a project funded by the RBWH Foundation, to examine small nerve fibre expression acutely and subacutely after motor vehicle accident, as a marker associated with the transition from acute to chronic pain.
  • Developed a chatbot for providing pain education for children and for adults,
  • Investigated the validity of phone apps for measuring the 6-minute walk test in people with persistent pain.
• Locally at the Tess Cramond Pain and Research Centre I co-lead annual projects for
  • quality improvement: UQ PHRM4071 student placement and Pain Medicine Trainee projects.
  • audit: ePPOC annual data reporting.
  • systematic reviews: UQ HRSS7801 group physiotherapy student project.

From 2004-2019 Andrew's PhD and postgraduate supervision as a lecturer in physiotherapy, focussed on how the brain controls posture and movement. This included studies of sitting, standing, stepping, squatting, pushing and postural control with low back pain and with adolescent idiopathic scoliosis. Extending understanding of postural control continues with colleagues at QUT Biomechanics and Spine Research Group (Prof Peter Pivonka, Maree Izatt and Assoc Prof Paige Little), the UQ Schools of ITEE (Dr Pauline Pounds) and SBMS Motor Control and Pain laboratory (Assoc Prof Kylie Tucker), and with Curtin University / UWA Raine cohort study (Prof Leon Straker).

I completed my undergraduate studies in Chemistry, History and German at the University of Sydney graduating with a University Medal, before completing a Bachelor of Laws and PhD in Chemistry at the same institution. I made extensive contributions towards university life during that time which was recognised by the award of the Convocation Medal. During the same period, I spent time on the board of the Australian Youth Orchestra and a regional Credit Union in NSW. I then spent two years on a prestigious Marie Curie Fellowship at the University of Cambridge where I was also a Director of Studies at Emmanuel College. I returned to Australia to join The University of Queensland in 2012. I became an ARC Future Fellow in 2014. I was awarded a 2015 Queensland Young Tall Poppy Award and the 2018 Malcolm McIntosh Prize for Physical Scientist of the Year. I have authored more than 200 publications including 4 book chapters, which have received over 7000 citations. I have an h-index of >42.

Geoffrey Cleghorn is Deputy Head of the School of Medicine, Director International of the School of Medicine and Professor of Paeditrics

Professor Cleghorn is a graduate of the University of Queensland Medical School and undertook postgraduate training in paediatric gastroenterology at the Hospital for Sick Children in Toronto Canada. Following his training he entered academic practice within University of Queensland at the Royal Children's Hospital in Brisbane.

Professor Cleghorn has published more than 90 manuscripts and book chapters and is a seasoned lecturer and public speaker on a number of infant related issues including perinatal and paediatric nutrition. His research interests include the use of energy expenditure and body composition analysis in a number of disease states including chronic liver disease, cystic fibrosis, and general nutritional rehabilitation. He has been the recipient of a number of research grants from national and international granting bodies including the Australian Research Council, the National Health & Medical Research Council from Australia and the National Institutes of Health from the USA.

Professor Cleghorn has developed an extensive network of associations throughout Asia and hence has a very high profile within this region. He is a frequent, invited visitor to countries throughout Asia and has spoken on a number of nutritional and gastrointestinal topics during these visits. This profile has enabled Professor Cleghorn to be formally appointed to the Academic Teaching Staff of the Department of Child Health, University of Indonesia as a visiting Professor, to become involved in several multinational trials in S.E. Asia, and has seen a number of trainees travel to Brisbane to further their paediatric gastrointestinal and nutritional studies with him and his colleagues.

Professor Cleghorn has been a member of the well respected, Queensland Liver Transplant Service from its inception in 1985 until the present day. He has been involved in many of the historical and seminal advances in paediatric liver transplantation including the world’s first successful living related donor liver transplant and the development of the liver cut down technique now universally known as the “Brisbane Technique”. Research from the QLTS has highlighted the importance of nutrition in these patients and again is now acknowledged internationally.

Professor Cleghorn has had extensive collaborative experience with all levels of industry from the conduct of commissioned trials for regulatory approval to board room advice. He has been on the medical advisory boards of the peak meat industry body in Australia and Gerber Australasia. He has had extensive experience within the broader Asian region providing advice to the regional medical office for Mead Johnson Nutritionals.

His memberships include the Queensland Paediatric Society, the Royal Australasian College of Physicians, the North American Society of Paediatric Gastroenterology and Nutrition, the European Society of Paediatric Gastroenterology Hepatology and Nutrition. In addition, he also holds the following positions:

• President – The Asian and Pacific Society of Paediatric Gastroenterology Hepatology and Nutrition
• President - The Federation of International Societies of Pediatric Gastroenterology, Hepatology & Nutrition
• Executive Councilor, The International Pediatric Transplantation Association
• Editorial Board, Journal of Gastroenterology and Hepatology
• Editorial Board, Bailiere’s Clinical Gastroenterology
• Visiting Professor, Faculty of Medicine, University of Indonesia

I grew up on a tiny farm in rural New Hampshire, but have travelled a lot since then, living in London, Los Angeles, Nashville, and most recently Christchurch, New Zealand. I earned my B.A. and M.A. degrees from the University of New Hampshire, and my Ph.D. from Vanderbilt University, and I have worked previously at the University of Canterbury in New Zealand.

Research

My research covers several areas including early modern literature and religion, adaptation studies, and the history of print culture. My first book, Reading Humility in Early Modern England (Ashgate 2015) argues for the importance of humility in sixteenth and seventeenth century English culture, and explores a range of texts from the period that engage with humility as a virtue, a trope, or a problem. My current book project focuses on early modern English sermons and emotions, and this project has also produced my most recent published articles.

I have published articles on Elizabeth I’s writing and on her afterlife in eighteenth century drama, on Shakespeare and adaptation, and on book history. Other areas of interest include the history of emotions, adaptation studies, especially film adaptation of Shakespeare, and the history of the book.

A community pharmacist and pharmacy owner, I primarily work as the Professional Services Pharmacist at the Good Price Pharmacy Warehouse Head Office. That role includes responsibility for QCPP accreditation, implementation of health programs and services, professional practice and regulatory compliance for the group. I oversee the group’s intern pharmacist recruitment and the delivery of our intern development program. I really enjoy mentoring students and young pharmacists to produce competent pharmacists. I firmly believe that community pharmacies have a role to play in delivering primary health care, especially as they are so accessible to their local communities. I am credentialed to vaccinate, am a Mental Health First Aider and have completed training in non-sterile compounding with Medisca.